Several studies proposed its combination with other targets such as acetylcholinesterase (AChE) and butyrylcholinesterase for AD (Gonzalez-Naranjo et al., 2013; Dolles et al., 2016, 2018; González-Naranjo et al., 2019). The gene discussed is ACHE; the disease is Alzheimer disease.